Repositioning autologous stem cell transplantation in the management of newly diagnosed multiple myeloma
DOI:
https://doi.org/10.46765/2675-374X.2023v4n3p205Palavras-chave:
Multiple myeloma, Stem cell transplantation, Immunotherapy, anti-CD38 monoclonal antibodies, Proteasome inhibitors, Immunomodulatory agentsResumo
.
Downloads
Publicado
27/12/2023
Como Citar
Crusoe, E., & Costa, L. (2023). Repositioning autologous stem cell transplantation in the management of newly diagnosed multiple myeloma. JBMTCT, 4(3), 205. https://doi.org/10.46765/2675-374X.2023v4n3p205
Edição
Seção
Artigos
Licença
Copyright (c) 2023 JBMTCT
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
